Immunic announced results from interim safety analysis from ongoing phase 2 CALVID-1 trial of IMU-838 in patients with COVID-19
On Sept. 28, 2020, Immunic announced the results of a pre-planned interim safety analysis and a recruitment update…
On Sept. 28, 2020, Immunic announced the results of a pre-planned interim safety analysis and a recruitment update…
On Sept. 23, 2020, a fourth Phase 3 clinical trial evaluating an investigational vaccine for coronavirus disease 2019…
On Sept. 23, 2020, Sinovac Biotech announced that the inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences,…
On Sept. 23, 2020, Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial…
On Sept. 22, 2020, Sinovac Biotech announced that it had recently commenced phase III clinical trials for its…
On Sept. 22, 2020, Oxford Immunotec announced that it had entered into an extensive research collaboration with Public…
On Sept. 15, 2020, BioNTech announced that it will receive a grant of up to 375 million Euro…
On Sept. 14, 2020, Pascal Biosciences and SoRSE Technology announced they had entered into a collaborative research agreement…
On Sept. 12 2020, Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK…
On Sept. 12, 2020, Pfizer and BioNTech announced that they had submitted an amended protocol to the FDA…
On Sept. 7, 2020, Pfizer and BioNTech announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the…
On Sept. 3, 2020, the U.S Department of Defense announced that as part of the Operation Warp Speed…
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
On Aug. 28, 2020, the U.S. Department of Veterans Affairs (VA) announced a new clinical trial to study…
On Aug. 19, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced that was the…
On Aug. 15, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to…
On Aug. 5, 2020, the National Institutes of Health (NIH) announced it had launched the Medical Imaging and…
On Aug. 5, 2020, BioNTech and Shanghai Fosun Pharmaceutical announced that the first 72 participants had been dosed…
On Aug. 4, 2020, Mateon Therapeutics and Abiogenesis announced they will be working together with Abiogenesis to initiate…
On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…
On Aug. 3, 2020, the University of Oxford and the COVID Symptom Study joined forces to widen access…
On Aug. 3, 2020, members of the COVID R&D Alliance AbbVie, Amgen and Takeda Pharma announced the first…
On Aug. 3, 2020, Eli Lilly announced the initiation of BLAZE-2, a phase 3 trial studying LY-CoV555 for…
On Aug. 3, 2020, Atossa Therapeutics announced that it had received approval from the ethics committee to open…
On Jul. 31, 2020, OraSure Technologies announced that its OMNIgene-ORAL (OM-505) saliva collection device is included in the…
On Jul. 30, 2020, RedHill Biopharma announced that it has initiated a global Phase 2/3 clinical study evaluating…
On Jul. 28, 2020, Apogenix announced that it had received regulatory approval to start a clinical phase II…
On Jul. 27, 2020, the Serum Institute of India announced that it was is conducting phase III clinical…
On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…
On Jul. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two new…